Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2677 |
|
Actual shortage: | 255 (10%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2413 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
24 (9%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-ESCITALOPRAM | 10MG | TABLET | Resolved | 2022-09-30 | 2022-12-02 | 170798 |
TEVA-ATORVASTATIN | 80MG | TABLET | Resolved | 2022-10-17 | 2023-01-12 | 172013 |
TEVA-FUROSEMIDE | 20MG | TABLET | Resolved | 2022-10-17 | 2023-07-12 | 172018 |
TEVA-AZATHIOPRINE | 50MG | TABLET | Resolved | 2022-10-28 | 2022-12-08 | 173010 |
TEVA-SUMATRIPTAN DF | 25MG | TABLET | Resolved | 2022-10-28 | 2022-11-12 | 173028 |
TEVA-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Resolved | 2022-10-28 | 2022-12-15 | 173031 |
ACT CIPROFLOXACIN | 750MG | TABLET | Resolved | 2022-10-28 | 2023-06-09 | 173040 |
TEVA-CEPHALEXIN | 250MG | TABLET | Resolved | 2022-10-28 | 2023-06-09 | 173049 |
TEVA-PROPRANOLOL | 20MG | TABLET | Resolved | 2022-10-28 | 2023-01-11 | 173055 |
TEVA-EVEROLIMUS | 2.5MG | TABLET | Resolved | 2022-10-28 | 2022-12-08 | 173058 |
TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2022-10-28 | 2023-01-12 | 173061 |
APRI 28 | 0.03MG 0.15MG | TABLET | Resolved | 2022-10-28 | 2022-12-02 | 173064 |
APRI 21 | 0.03MG 0.15MG | TABLET | Resolved | 2022-10-28 | 2022-12-02 | 173067 |
TEVA-NAPROXEN | 500MG | TABLET | Resolved | 2022-11-14 | 2023-01-19 | 174583 |
TEVA-ATORVASTATIN | 20MG | TABLET | Resolved | 2022-11-14 | 2023-01-12 | 174586 |
TEVA-ATORVASTATIN | 10MG | TABLET | Resolved | 2022-11-14 | 2023-04-28 | 174589 |
TEVA-PRAZOSIN | 1MG | TABLET | Actual shortage | 2022-11-14 | 2023-12-21 | 174592 |
TEVA-CARVEDILOL | 3.125MG | TABLET | Resolved | 2022-11-14 | 2023-02-09 | 174598 |
TEVA-CARVEDILOL | 6.25MG | TABLET | Resolved | 2022-11-14 | 2023-02-09 | 174601 |
TEVA-ATENOLOL | 50MG | TABLET | Resolved | 2022-11-14 | 2023-10-05 | 174610 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-PIOGLITAZONE | 15MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65026 |
TEVA-PIOGLITAZONE | 30MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65030 |
TEVA-PIOGLITAZONE | 45MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65033 |
TEVA-QUETIAPINE | 100MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65036 |
TEVA-QUETIAPINE | 200MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65039 |
TEVA-QUETIAPINE | 25MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65044 |
TEVA-QUETIAPINE | 300MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65047 |
ACT ZOPICLONE | 5MG | TABLET | Discontinued | 2018-10-22 | 2018-10-22 | 65191 |
ACT ZOPICLONE | 7.5MG | TABLET | Discontinued | 2018-10-22 | 2018-10-22 | 65213 |
ACT ZOPICLONE | 7.5MG | TABLET | Discontinued | 2018-10-22 | 2018-10-22 | 65218 |
ACT ETIDROCAL | 400MG 500MG | TABLET | Discontinued | 2019-02-21 | 2019-03-01 | 76486 |
TEVA-LISINOPRIL (TYPE P) | 5MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81298 |
TEVA-LISINOPRIL/HCTZ (TYPE P) | 12.5MG 20MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81301 |
NOVO-PROFEN | 200MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81310 |
TEVA-PAROXETINE | 10MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81313 |
TEVA-NAPROXEN SODIUM DS | 550MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81350 |
TEVA-LENOLTEC NO. 1 | 300MG 8MG 15MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81362 |
TEVA-LISINOPRIL/HCTZ (TYPE P) | 25MG 20MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81368 |
TEVA-FAMOTIDINE | 20MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81371 |
TEVA-PREDNISONE | 5MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81376 |